Delivery Order SPE2DB22D1017-SPE2DB24FF7NQ
- Not listed
- This federal contract award, valued at $3,153.54, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Atorvastatin Calcium, a pharmaceutical product, with a completion date of September 10, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply...
- This federal contract award is a delivery order with a firm fixed price of $2,594.95 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which has no set-aside designation, was made by the Defense Logistics Agency (DLA) to support medical supply chain requirements for the U.S. Department of Defense. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,258.40 Firm Fixed Price Delivery Order is a non-set-aside award for the supply of various pharmaceutical products and medical supplies to support military healthcare programs. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $79,347.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract with a firm fixed price, which will run through May 6, 2025. Amerisourcebergen Drug Corp is a for-profit organization that has held a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,447.18 firm fixed-price delivery order contract is for the supply of various pharmaceutical and medical products, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The contract has no set-aside designation, indicating open competition....
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a Firm Fixed Price valued at $1,354.50. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to provide a variety of pharmaceutical products and medical supplies. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at...
- This federal contract award, valued at $34,139.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
- This federal contract award is a $474,256.03 firm fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award was made by the Defense Logistics Agency (DLA), which serves as a critical supplier of medical and pharmaceutical products to federal agencies. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,640.27 Firm Fixed Price Delivery Order contract has an ultimate completion date of May 9, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $2,279.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides comprehensive global pharmaceutical support services to the Defense Health Agency, U.S. Coast Guard, and other government agencies....
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF7NQDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,154.47 Firm Fixed Price delivery order is for the supply of Rosuvastatin Calcium 10 mg tablets to DLA facilities. The award is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 5/10/24 |